Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study
Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the phys...
Gespeichert in:
Veröffentlicht in: | Journal of the American Medical Directors Association 2017-10, Vol.18 (10), p.848-852 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 852 |
---|---|
container_issue | 10 |
container_start_page | 848 |
container_title | Journal of the American Medical Directors Association |
container_volume | 18 |
creator | Rolland, Yves, MD, PhD Dupuy, Charlotte, PhD Abellan Van Kan, Gabor, MD, PhD Cesari, Matteo, MD, PhD Vellas, Bruno, MD, PhD Faruch, Marie, MD Dray, Cedric, MD, PhD de Souto Barreto, Philipe, PhD |
description | Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance. |
doi_str_mv | 10.1016/j.jamda.2017.05.010 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1911701433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525861017302773</els_id><sourcerecordid>1911701433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</originalsourceid><addsrcrecordid>eNqFkUtv1DAUhSNERR_wC5CQl2wS_BjbCRJIo1EfSJUoBMTS8tg3qkMSD3aClH9fmyks2HTluzjnHp_vFsVrgiuCiXjXV70era4oJrLCvMIEPyvOCGd12TDJn-eZ8rIWBJ8W5zH2GCdpI14Up7QWtJFEnhWx1cH4A0xOo9YEgAks2q9ovgfUbr_uyiv0ZYE4Oz9N2gVAerLo7n6NzugB3UHofBj1ZCAi36HLwUIYVvTDjzC9R1u0Cz7GsgWTFyRDOy92fVmcdHqI8OrxvSi-X11-292Ut5-vP-22t6XZ1HguDeaNYEzTuu5EzQ0HYTnjrOm6De5qSwVIJsieYQFUEttJymq9x1QLwxtg7KJ4e9x7CP5XLqFGFw0Mg57AL1GRhhCJyYZlKTtKTf5wgE4dght1WBXBKtNWvfpDW2XaCnOVaCfXm8eAZT-C_ef5izcJPhwFkGr-dhBUNA4SLZtQmllZ754I-Pif3wxuyuh_wgqx90tIVFMTFanCqs0Hz_dO0ZhKydgDa3WlSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1911701433</pqid></control><display><type>article</type><title>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Rolland, Yves, MD, PhD ; Dupuy, Charlotte, PhD ; Abellan Van Kan, Gabor, MD, PhD ; Cesari, Matteo, MD, PhD ; Vellas, Bruno, MD, PhD ; Faruch, Marie, MD ; Dray, Cedric, MD, PhD ; de Souto Barreto, Philipe, PhD</creator><creatorcontrib>Rolland, Yves, MD, PhD ; Dupuy, Charlotte, PhD ; Abellan Van Kan, Gabor, MD, PhD ; Cesari, Matteo, MD, PhD ; Vellas, Bruno, MD, PhD ; Faruch, Marie, MD ; Dray, Cedric, MD, PhD ; de Souto Barreto, Philipe, PhD</creatorcontrib><description>Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance.</description><identifier>ISSN: 1525-8610</identifier><identifier>EISSN: 1538-9375</identifier><identifier>DOI: 10.1016/j.jamda.2017.05.010</identifier><identifier>PMID: 28629717</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Female ; France - epidemiology ; Geriatric Assessment ; Hand Strength ; Humans ; Internal Medicine ; Medical Education ; physical performances ; SARC-F ; Sarcopenia ; Sarcopenia - diagnosis ; Sarcopenia - epidemiology ; screening ; Surveys and Questionnaires ; Walking Speed</subject><ispartof>Journal of the American Medical Directors Association, 2017-10, Vol.18 (10), p.848-852</ispartof><rights>AMDA – The Society for Post-Acute and Long-Term Care Medicine</rights><rights>2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine</rights><rights>Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</citedby><cites>FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jamda.2017.05.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28629717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rolland, Yves, MD, PhD</creatorcontrib><creatorcontrib>Dupuy, Charlotte, PhD</creatorcontrib><creatorcontrib>Abellan Van Kan, Gabor, MD, PhD</creatorcontrib><creatorcontrib>Cesari, Matteo, MD, PhD</creatorcontrib><creatorcontrib>Vellas, Bruno, MD, PhD</creatorcontrib><creatorcontrib>Faruch, Marie, MD</creatorcontrib><creatorcontrib>Dray, Cedric, MD, PhD</creatorcontrib><creatorcontrib>de Souto Barreto, Philipe, PhD</creatorcontrib><title>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</title><title>Journal of the American Medical Directors Association</title><addtitle>J Am Med Dir Assoc</addtitle><description>Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Geriatric Assessment</subject><subject>Hand Strength</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical Education</subject><subject>physical performances</subject><subject>SARC-F</subject><subject>Sarcopenia</subject><subject>Sarcopenia - diagnosis</subject><subject>Sarcopenia - epidemiology</subject><subject>screening</subject><subject>Surveys and Questionnaires</subject><subject>Walking Speed</subject><issn>1525-8610</issn><issn>1538-9375</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1DAUhSNERR_wC5CQl2wS_BjbCRJIo1EfSJUoBMTS8tg3qkMSD3aClH9fmyks2HTluzjnHp_vFsVrgiuCiXjXV70era4oJrLCvMIEPyvOCGd12TDJn-eZ8rIWBJ8W5zH2GCdpI14Up7QWtJFEnhWx1cH4A0xOo9YEgAks2q9ovgfUbr_uyiv0ZYE4Oz9N2gVAerLo7n6NzugB3UHofBj1ZCAi36HLwUIYVvTDjzC9R1u0Cz7GsgWTFyRDOy92fVmcdHqI8OrxvSi-X11-292Ut5-vP-22t6XZ1HguDeaNYEzTuu5EzQ0HYTnjrOm6De5qSwVIJsieYQFUEttJymq9x1QLwxtg7KJ4e9x7CP5XLqFGFw0Mg57AL1GRhhCJyYZlKTtKTf5wgE4dght1WBXBKtNWvfpDW2XaCnOVaCfXm8eAZT-C_ef5izcJPhwFkGr-dhBUNA4SLZtQmllZ754I-Pif3wxuyuh_wgqx90tIVFMTFanCqs0Hz_dO0ZhKydgDa3WlSw</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Rolland, Yves, MD, PhD</creator><creator>Dupuy, Charlotte, PhD</creator><creator>Abellan Van Kan, Gabor, MD, PhD</creator><creator>Cesari, Matteo, MD, PhD</creator><creator>Vellas, Bruno, MD, PhD</creator><creator>Faruch, Marie, MD</creator><creator>Dray, Cedric, MD, PhD</creator><creator>de Souto Barreto, Philipe, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20171001</creationdate><title>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</title><author>Rolland, Yves, MD, PhD ; Dupuy, Charlotte, PhD ; Abellan Van Kan, Gabor, MD, PhD ; Cesari, Matteo, MD, PhD ; Vellas, Bruno, MD, PhD ; Faruch, Marie, MD ; Dray, Cedric, MD, PhD ; de Souto Barreto, Philipe, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Geriatric Assessment</topic><topic>Hand Strength</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical Education</topic><topic>physical performances</topic><topic>SARC-F</topic><topic>Sarcopenia</topic><topic>Sarcopenia - diagnosis</topic><topic>Sarcopenia - epidemiology</topic><topic>screening</topic><topic>Surveys and Questionnaires</topic><topic>Walking Speed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rolland, Yves, MD, PhD</creatorcontrib><creatorcontrib>Dupuy, Charlotte, PhD</creatorcontrib><creatorcontrib>Abellan Van Kan, Gabor, MD, PhD</creatorcontrib><creatorcontrib>Cesari, Matteo, MD, PhD</creatorcontrib><creatorcontrib>Vellas, Bruno, MD, PhD</creatorcontrib><creatorcontrib>Faruch, Marie, MD</creatorcontrib><creatorcontrib>Dray, Cedric, MD, PhD</creatorcontrib><creatorcontrib>de Souto Barreto, Philipe, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Medical Directors Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rolland, Yves, MD, PhD</au><au>Dupuy, Charlotte, PhD</au><au>Abellan Van Kan, Gabor, MD, PhD</au><au>Cesari, Matteo, MD, PhD</au><au>Vellas, Bruno, MD, PhD</au><au>Faruch, Marie, MD</au><au>Dray, Cedric, MD, PhD</au><au>de Souto Barreto, Philipe, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</atitle><jtitle>Journal of the American Medical Directors Association</jtitle><addtitle>J Am Med Dir Assoc</addtitle><date>2017-10-01</date><risdate>2017</risdate><volume>18</volume><issue>10</issue><spage>848</spage><epage>852</epage><pages>848-852</pages><issn>1525-8610</issn><eissn>1538-9375</eissn><abstract>Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28629717</pmid><doi>10.1016/j.jamda.2017.05.010</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-8610 |
ispartof | Journal of the American Medical Directors Association, 2017-10, Vol.18 (10), p.848-852 |
issn | 1525-8610 1538-9375 |
language | eng |
recordid | cdi_proquest_miscellaneous_1911701433 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Aged Aged, 80 and over Cross-Sectional Studies Female France - epidemiology Geriatric Assessment Hand Strength Humans Internal Medicine Medical Education physical performances SARC-F Sarcopenia Sarcopenia - diagnosis Sarcopenia - epidemiology screening Surveys and Questionnaires Walking Speed |
title | Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T01%3A39%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sarcopenia%20Screened%20by%20the%20SARC-F%20Questionnaire%20and%20Physical%20Performances%20of%20Elderly%20Women:%20A%20Cross-Sectional%20Study&rft.jtitle=Journal%20of%20the%20American%20Medical%20Directors%20Association&rft.au=Rolland,%20Yves,%20MD,%20PhD&rft.date=2017-10-01&rft.volume=18&rft.issue=10&rft.spage=848&rft.epage=852&rft.pages=848-852&rft.issn=1525-8610&rft.eissn=1538-9375&rft_id=info:doi/10.1016/j.jamda.2017.05.010&rft_dat=%3Cproquest_cross%3E1911701433%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1911701433&rft_id=info:pmid/28629717&rft_els_id=S1525861017302773&rfr_iscdi=true |